Paul Tudor Jones Regeneron Pharmaceuticals, Inc. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 37,651 shares of REGN stock, worth $26.7 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

37,651

Holding current value

$26.7 Million

% of portfolio

0.15%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $38.6 Million - $45.2 Million	37,651 New	37,651 $39.6 Million
Q3 2023 Nov 15, 2023	SELL	$692.45 - $844.37 $5.43 Million - $6.63 Million	-7,847 Reduced 57.5%	5,799 $4.77 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $7.4 Million - $8.78 Million	10,574 Added 344.21%	13,646 $9.81 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $368,825 - $448,217	-542 Reduced 15.0%	3,072 $2.52 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $2.55 Million - $2.77 Million	3,614 New	3,614 $2.61 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $926,711 - $1.25 Million	1,690 New	1,690 $999,000
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $913,281 - $1.08 Million	-1,591 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $752,224 - $888,637	1,591 New	1,591 $889,000
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $1.2 Million - $1.56 Million	-2,426 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $897,600 - $1.32 Million	-2,670 Reduced 52.39%	2,426 $1.19 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $1.4 Million - $1.92 Million	5,096 New	5,096 $1.91 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $214,666 - $249,936	-785 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $494,340 - $684,453	-1,650 Reduced 67.76%	785 $246,000
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $906,014 - $1.07 Million	2,435 New	2,435 $1 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $429,177 - $515,085	-1,278 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $2.72 Million - $3.17 Million	-7,754 Reduced 85.85%	1,278 $516,000
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $2.57 Million - $3.12 Million	9,032 New	9,032 $3.12 Million
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $1.27 Million - $1.58 Million	-4,017 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $1.44 Million - $1.89 Million	4,017	4,017 $1.51 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account